Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Optimizing the manufacturing and antitumour response of CAR T therapy
Yutong Liu, Adam S. Sperling, Eric L. Smith, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 4, pp. 271-285
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Responsive biomaterials: optimizing control of cancer immunotherapy
Lulu Xue, Ajay S. Thatte, David Mai, et al.
Nature Reviews Materials (2023) Vol. 9, Iss. 2, pp. 100-118
Closed Access | Times Cited: 52
CAR T cells for treating autoimmune diseases
Ulrich Blache, Sandy Tretbar, Ulrike Koehl, et al.
RMD Open (2023) Vol. 9, Iss. 4, pp. e002907-e002907
Open Access | Times Cited: 39
CAR-T cell therapy for hematological malignancies: History, status and promise
Chao Wang, Jianpeng Wang, Shusheng Che, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21776-e21776
Open Access | Times Cited: 24
Biomaterials to enhance adoptive cell therapy
Noah Eckman, Anahita Nejatfard, Romola Cavet, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 5, pp. 408-424
Closed Access | Times Cited: 15
Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies
Shengkang Huang, Xinyu Wang, Yu Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 19
Engineering Challenges and Opportunities in Autologous Cellular Cancer Immunotherapy
Colleen Foley, Sheridan L. Swan, Melody A. Swartz
The Journal of Immunology (2024) Vol. 212, Iss. 2, pp. 188-198
Closed Access | Times Cited: 7
Mechanical forces amplify TCR mechanotransduction in T cell activation and function
Nicholas Jeffreys, Joshua M. Brockman, Yunhao Zhai, et al.
Applied Physics Reviews (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 6
Chimeric antigen receptor T cell therapy: a new emerging landscape in autoimmune rheumatic diseases
Xia Lyu, Latika Gupta, Eleni Tholouli, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 5, pp. 1206-1216
Open Access | Times Cited: 12
Electrotransfer for nucleic acid and protein delivery
Aswin Muralidharan, Pouyan E. Boukany
Trends in biotechnology (2023) Vol. 42, Iss. 6, pp. 780-798
Open Access | Times Cited: 11
Role of T-cells in immunotherapy of pancreatic and colon cancers
Ashni Dudhia, Mia Rajan, Keshav Patel, et al.
Elsevier eBooks (2025), pp. 233-244
Closed Access
Precise CAR-T-cell Therapy Targeting Non-Cancerous Diseases: Advances in Precision Medicine and Bioengineering
Chaojie Zhu, Fangzhou Wang, Zesheng Cheng, et al.
Precision medicine and engineering. (2025), pp. 100024-100024
Open Access
A review of antibody-based immunotherapy clinical trials for adult acute myeloid leukemia (AML): monoclonal antibodies (mAbs) and beyond
Kaitlyn C Dykes, Edward D. Ball
Expert Opinion on Biological Therapy (2025)
Closed Access
Depletion of CD8+ CAR T-cells leads to superior anti-tumor efficacy of pure CD4+ CAR T-cells against Acute Leukemias
Tim Sauer, Qian Chen, Hao Yao, et al.
Research Square (Research Square) (2025)
Closed Access
Cellular Therapies: From a Theoretical Concept to an Immuno-augmented Reality
Pratima Cherukuri, Aalia Khan, Karan Gera, et al.
(2025), pp. 121-170
Closed Access
Engineering T-cell receptor–like antibodies for biologics and cell therapy
Lene S. Høydahl, Gøril Berntzen, Geir Åge Løset
Current Opinion in Biotechnology (2024) Vol. 90, pp. 103224-103224
Closed Access | Times Cited: 3
Biomaterials mimicking immunological synapses for enhanced T cell activation in CAR-T therapy
Yan-Ruide Li, Zeyang Liu, Enbo Zhu
Science Bulletin (2025)
Open Access
Model‐informed drug development of autologous CAR‐T cell therapy: Strategies to optimize CAR‐T cell exposure leveraging cell kinetic/dynamic modeling
Anna M. Mc Laughlin, Peter A. Milligan, Cassian Yee, et al.
CPT Pharmacometrics & Systems Pharmacology (2023) Vol. 12, Iss. 11, pp. 1577-1590
Open Access | Times Cited: 8
CAR‐Aptamers Enable Traceless Enrichment and Monitoring of CAR‐Positive Cells and Overcome Tumor Immune Escape
Hang Zhou, Tuersunayi Abudureheman, Wei‐Wei Zheng, et al.
Advanced Science (2023) Vol. 11, Iss. 10
Open Access | Times Cited: 8
Harnessing the Transcriptional Signatures of CAR-T-Cells and Leukemia/Lymphoma Using Single-Cell Sequencing Technologies
Yu‐Mei Liao, Shih‐Hsien Hsu, Shyh‐Shin Chiou
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2416-2416
Open Access | Times Cited: 3
Spiky Gold Nanoparticles, a Nanoscale Approach to Enhanced Ex Vivo T-Cell Activation
Fatemeh Esmaeili, Yuhao Leo Wu, Zongjie Wang, et al.
ACS Nano (2024) Vol. 18, Iss. 32, pp. 21554-21564
Closed Access | Times Cited: 3
An Oral PROTAC Targeting HPK1 Degradation Potentiates Anti‐Solid Tumor Immunity
Yuejun Yao, Mingfei Wu, Yanfang Wang, et al.
Advanced Materials (2024)
Closed Access | Times Cited: 1
Harnessing the Transcriptional Signatures of Car-T Cells and Leukemia/Lymphoma Using Single-Cell Sequencing Technologies
Yu‐Mei Liao, Shih‐Hsien Hsu, Shyh‐Shin Chiou
(2024)
Open Access | Times Cited: 1
Allogeneic and other innovative chimeric antigen receptor platforms
Andrew Jallouk, Salyka Sengsayadeth, Bipin N. Savani, et al.
Clinical Hematology International (2024) Vol. 6, Iss. 3
Open Access
Reprogramming tumor cells to fight cancer
Haibo Zhou, Li Wu
Science (2024) Vol. 386, Iss. 6719, pp. 274-275
Closed Access
Bridging the gender gap in autoimmunity with T-cell–targeted biomaterials
Aida López Ruiz, Eric D Slaughter, April M. Kloxin, et al.
Current Opinion in Biotechnology (2024) Vol. 86, pp. 103075-103075
Closed Access
Page 1 - Next Page

Scroll to top